Skip to main content
Erschienen in: Immunologic Research 2/2017

19.01.2017 | Novel Aspects in Lupus, 2017

Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature

verfasst von: Pikman Regina, Rotman Pnina, Aiman Natur, Levy Yair

Erschienen in: Immunologic Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Anti-phospholipid syndrome is an autoimmune disorder characterized by anti-phospholipid antibodies, arterial and venous thrombosis, pregnancy morbidity, and various neurological manifestations including psychiatric disorders. Higher incidence of various autoimmune disorders was found in schizophrenia. In addition, an association between the presence of anti-phospholipid antibodies and schizophrenia or psychosis was previously described, mainly as case reports. Although initially believed to be a result of neuroleptic treatment, the reasons for this association remain obscure. Several theories on the etiologic basis of schizophrenia that may explain this association were proposed including an immune basis of schizophrenia and a genetic locus of the disease in the human leukocyte antigens area. Herein, we present a series of five patients diagnosed with both schizophrenia and anti-phospholipid syndrome and their characteristics along with a comprehensive review of the current available literature on the subject in an attempt to deepen our understanding of these disorders and their pathogenesis.
Literatur
1.
Zurück zum Zitat Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752–63.CrossRefPubMed Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752–63.CrossRefPubMed
2.
Zurück zum Zitat Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–27.CrossRefPubMed Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–27.CrossRefPubMed
3.
Zurück zum Zitat Amoroso A, Mitterhofer AP, Ferri GM, et al. Neurological involvement in antiphospholipid antibodies syndrome (APS). Eur Rev Med Pharmacol Sci. 1999;3(5):205–9.PubMed Amoroso A, Mitterhofer AP, Ferri GM, et al. Neurological involvement in antiphospholipid antibodies syndrome (APS). Eur Rev Med Pharmacol Sci. 1999;3(5):205–9.PubMed
4.
Zurück zum Zitat Kirch DG. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr Bull. 1993;19:355–70.CrossRefPubMed Kirch DG. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr Bull. 1993;19:355–70.CrossRefPubMed
5.
Zurück zum Zitat Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011;168(12):1303–10.CrossRefPubMed Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011;168(12):1303–10.CrossRefPubMed
6.
Zurück zum Zitat Chengappa KN, Nimgaonkar VL, Bachert C, et al. Obstetric complications and autoantibodies in schizophrenia. Acta Psychiatr Scand. 1995;92:270–3.CrossRefPubMed Chengappa KN, Nimgaonkar VL, Bachert C, et al. Obstetric complications and autoantibodies in schizophrenia. Acta Psychiatr Scand. 1995;92:270–3.CrossRefPubMed
7.
Zurück zum Zitat Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163:521–8.CrossRefPubMed Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163:521–8.CrossRefPubMed
8.
Zurück zum Zitat Ganguli R, Brar JS, Chengappa KN, et al. Autoimmunity in schizophrenia: a review of recent findings. Ann Med. 1993;25:489–96.CrossRefPubMed Ganguli R, Brar JS, Chengappa KN, et al. Autoimmunity in schizophrenia: a review of recent findings. Ann Med. 1993;25:489–96.CrossRefPubMed
9.
Zurück zum Zitat Wright P, Donaldson PT, Underhill JA, et al. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry. 1996;153:1530–3.CrossRefPubMed Wright P, Donaldson PT, Underhill JA, et al. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry. 1996;153:1530–3.CrossRefPubMed
11.
Zurück zum Zitat Chang SH, Chiang SY, Chiu CC, Tsai CC, Tsai HH, Huang CY, Hsu TC, Tzang BS. Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients withschizophrenia. Psychiatry Res. 2011;187(3):341–6.CrossRefPubMed Chang SH, Chiang SY, Chiu CC, Tsai CC, Tsai HH, Huang CY, Hsu TC, Tzang BS. Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients withschizophrenia. Psychiatry Res. 2011;187(3):341–6.CrossRefPubMed
12.
Zurück zum Zitat Ezeoke A, Mellor A, Buckley P, Miller B. A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res. 2013;150(1):245–51.CrossRefPubMed Ezeoke A, Mellor A, Buckley P, Miller B. A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res. 2013;150(1):245–51.CrossRefPubMed
13.
Zurück zum Zitat Bechter K. Updating the mild encephalitis hypothesis ofschizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;42:71–91.CrossRef Bechter K. Updating the mild encephalitis hypothesis ofschizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;42:71–91.CrossRef
14.
Zurück zum Zitat Masdeu JC, Dalmau J, Berman KF 2016. NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis? Trends Neurosci Masdeu JC, Dalmau J, Berman KF 2016. NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis? Trends Neurosci
16.
Zurück zum Zitat Kramina S, Kevere L, Bezborodovs N, Purvina S, Rozentals G, Strautmanis J, Viksna Z. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: case report. Psych J. 2015;4(4):226–30.CrossRefPubMed Kramina S, Kevere L, Bezborodovs N, Purvina S, Rozentals G, Strautmanis J, Viksna Z. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: case report. Psych J. 2015;4(4):226–30.CrossRefPubMed
17.
Zurück zum Zitat Huang C, Kang Y, Zhang B, Li B, Qiu C, Liu S, Ren H, Yang Y, Liu X, Li T, Guo W. Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed asschizophrenia: complexities in diagnosis and treatment. Neuropsychiatr Dis Treat. 2015;11:1437–42.PubMedPubMedCentral Huang C, Kang Y, Zhang B, Li B, Qiu C, Liu S, Ren H, Yang Y, Liu X, Li T, Guo W. Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed asschizophrenia: complexities in diagnosis and treatment. Neuropsychiatr Dis Treat. 2015;11:1437–42.PubMedPubMedCentral
18.
Zurück zum Zitat Cleland N, Lieblich S, Schalling M, Rahm C. A 16-year-old girl with anti-NMDA-receptor encephalitis and family history of psychotic disorders. Acta Neuropsychiatr. 2015;27(6):375–9.CrossRefPubMed Cleland N, Lieblich S, Schalling M, Rahm C. A 16-year-old girl with anti-NMDA-receptor encephalitis and family history of psychotic disorders. Acta Neuropsychiatr. 2015;27(6):375–9.CrossRefPubMed
19.
Zurück zum Zitat Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, Shoenfeld Y. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus. 2003;12(7):514–7.CrossRefPubMed Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, Shoenfeld Y. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus. 2003;12(7):514–7.CrossRefPubMed
20.
Zurück zum Zitat Sokol DK, O’Brien RS, Wagenknecht DR, Rao T, McIntyre JA. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis. J Neuroimmunol. 2007;190(1–2):151–6.CrossRefPubMed Sokol DK, O’Brien RS, Wagenknecht DR, Rao T, McIntyre JA. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis. J Neuroimmunol. 2007;190(1–2):151–6.CrossRefPubMed
21.
Zurück zum Zitat Canoso RT, de Oliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Hematol. 1988;27(4):272–5.CrossRefPubMed Canoso RT, de Oliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Hematol. 1988;27(4):272–5.CrossRefPubMed
22.
Zurück zum Zitat Shen H, Li R, Xiao H, Zhou Q, Cui Q, Chen J. Higher serum clozapine level is associated with increased antiphospholipid antibodies inschizophrenia patients. J Psychiatr Res. 2009;43(6):615–9.CrossRefPubMed Shen H, Li R, Xiao H, Zhou Q, Cui Q, Chen J. Higher serum clozapine level is associated with increased antiphospholipid antibodies inschizophrenia patients. J Psychiatr Res. 2009;43(6):615–9.CrossRefPubMed
23.
Zurück zum Zitat Schwartz M, Rochas M, Weller B, Sheinkman A, Tal I, Golan D, Toubi N, Eldar I, Sharf B, Attias D. High association of anticardiolipin antibodies with psychosis. J Clin Psychiatry. 1998;59(1):20–3.CrossRefPubMed Schwartz M, Rochas M, Weller B, Sheinkman A, Tal I, Golan D, Toubi N, Eldar I, Sharf B, Attias D. High association of anticardiolipin antibodies with psychosis. J Clin Psychiatry. 1998;59(1):20–3.CrossRefPubMed
24.
Zurück zum Zitat Firer M, Sirota P, Schild K, Elizur A, Slor H. Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia. J Clin Immunol. 1994;14(1):73–8.CrossRefPubMed Firer M, Sirota P, Schild K, Elizur A, Slor H. Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia. J Clin Immunol. 1994;14(1):73–8.CrossRefPubMed
25.
Zurück zum Zitat Delluc A, Rousseau A, Le Galudec M, Canceil O, Woodhams B, Etienne S, Walter M, Mottier D, Van Dreden P, Lacut K. Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics. Br J Haematol. 2014;164(2):272–9.CrossRefPubMed Delluc A, Rousseau A, Le Galudec M, Canceil O, Woodhams B, Etienne S, Walter M, Mottier D, Van Dreden P, Lacut K. Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics. Br J Haematol. 2014;164(2):272–9.CrossRefPubMed
26.
Zurück zum Zitat Kolyaskina GI, Burbaeva OA, Sekirina TP. Anticardiolipin antibodies in schizophrenia Kolyaskina GI, Burbaeva OA, Sekirina TP. Anticardiolipin antibodies in schizophrenia
27.
Zurück zum Zitat Kurtz G, Müller N. The antiphospholipid syndrome and psychosis. Am J Psychiatry. 1994;151(12):1841–2.CrossRefPubMed Kurtz G, Müller N. The antiphospholipid syndrome and psychosis. Am J Psychiatry. 1994;151(12):1841–2.CrossRefPubMed
28.
Zurück zum Zitat Cardinal RN, Shah DN, Edwards CJ, Hughes GR, Fernández-Egea E. Psychosis and catatonia as a first presentation of antiphospholipid syndrome. Br J Psychiatry. 2009;195(3):272.CrossRefPubMed Cardinal RN, Shah DN, Edwards CJ, Hughes GR, Fernández-Egea E. Psychosis and catatonia as a first presentation of antiphospholipid syndrome. Br J Psychiatry. 2009;195(3):272.CrossRefPubMed
29.
Zurück zum Zitat Fernández Ga de Las Heras V, Gorriti MA, García-Vicuña R, Santos Ruiz JL. Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report. Rheumatol Int. 2007;27(9):883–5. Fernández Ga de Las Heras V, Gorriti MA, García-Vicuña R, Santos Ruiz JL. Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report. Rheumatol Int. 2007;27(9):883–5.
30.
Zurück zum Zitat Eaton WW, Hayward C, Ram R. Schizophrenia and rheumatoid arthritis: a review. Schizophr Res. 1992;6:181–92.CrossRefPubMed Eaton WW, Hayward C, Ram R. Schizophrenia and rheumatoid arthritis: a review. Schizophr Res. 1992;6:181–92.CrossRefPubMed
31.
Zurück zum Zitat Gilvarry CM, Sham PC, Jones PB, et al. Family history of autoimmune diseases in psychosis. Schizophr Res. 1996;19:33–40.CrossRefPubMed Gilvarry CM, Sham PC, Jones PB, et al. Family history of autoimmune diseases in psychosis. Schizophr Res. 1996;19:33–40.CrossRefPubMed
32.
Zurück zum Zitat DeLisi LE, Boccio AM, Riordan H, et al. Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Res. 1991;38:39–50.CrossRefPubMed DeLisi LE, Boccio AM, Riordan H, et al. Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Res. 1991;38:39–50.CrossRefPubMed
33.
Zurück zum Zitat Eaton W, Mortensen PB, Agerbo E, et al. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ. 2004;328:438–9.CrossRefPubMedPubMedCentral Eaton W, Mortensen PB, Agerbo E, et al. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ. 2004;328:438–9.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Chen SJ, Chao YL, Chen CY, Chang CM, Wu EC, Wu CS, Yeh HH, Chen CH, Tsai HJ. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry. 2012;200(5):374–80.CrossRefPubMed Chen SJ, Chao YL, Chen CY, Chang CM, Wu EC, Wu CS, Yeh HH, Chen CH, Tsai HJ. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry. 2012;200(5):374–80.CrossRefPubMed
35.
Zurück zum Zitat Benros ME, Eaton WW, Mortensen PB. The epidemiologic evidence linking autoimmunediseases and psychosis. Biol Psychiatry. 2014;75(4):300–6.CrossRefPubMed Benros ME, Eaton WW, Mortensen PB. The epidemiologic evidence linking autoimmunediseases and psychosis. Biol Psychiatry. 2014;75(4):300–6.CrossRefPubMed
36.
Zurück zum Zitat Metzer WS, Canoso RT, Newton JE. Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy. South Med J. 1994;87(2):190–2.CrossRefPubMed Metzer WS, Canoso RT, Newton JE. Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy. South Med J. 1994;87(2):190–2.CrossRefPubMed
37.
Zurück zum Zitat Jönsson AK, Spigset O, Hägg S. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. CNS Drugs. 2012;26(8):649–62.CrossRefPubMed Jönsson AK, Spigset O, Hägg S. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. CNS Drugs. 2012;26(8):649–62.CrossRefPubMed
38.
Zurück zum Zitat Masopust J, Malý R, Vališ M. Risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66(7):541–52.CrossRefPubMed Masopust J, Malý R, Vališ M. Risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66(7):541–52.CrossRefPubMed
39.
Zurück zum Zitat Ducloux D, Florea A, Fournier V, Rebibou JM, Chalopin JM. Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies. Nephrol Dial Transplant. 1999;14(5):1335–6.CrossRefPubMed Ducloux D, Florea A, Fournier V, Rebibou JM, Chalopin JM. Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies. Nephrol Dial Transplant. 1999;14(5):1335–6.CrossRefPubMed
40.
Zurück zum Zitat Henneberg AE, Horter S, Ruffert S. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients. Schizophr Res. 1994;14(1):15–22.CrossRefPubMed Henneberg AE, Horter S, Ruffert S. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients. Schizophr Res. 1994;14(1):15–22.CrossRefPubMed
41.
Zurück zum Zitat Margari F, Petruzzelli MG, Mianulli R, Toto M, Pastore A, Bizzaro N, Tampoia M. Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study. Psychiatry Res. 2013;210(3):800–5.CrossRefPubMed Margari F, Petruzzelli MG, Mianulli R, Toto M, Pastore A, Bizzaro N, Tampoia M. Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study. Psychiatry Res. 2013;210(3):800–5.CrossRefPubMed
42.
Zurück zum Zitat Lévy-Soussan P, Berneman A, Poirier MF, et al. Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals. J Psychiatry Neurosci. 1996 Mar;21(2):89–95.PubMedPubMedCentral Lévy-Soussan P, Berneman A, Poirier MF, et al. Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals. J Psychiatry Neurosci. 1996 Mar;21(2):89–95.PubMedPubMedCentral
43.
Zurück zum Zitat Chengappa KN, Carpenter AB, Keshavan MS, et al. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry. 1991;30(7):731–5.CrossRefPubMed Chengappa KN, Carpenter AB, Keshavan MS, et al. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry. 1991;30(7):731–5.CrossRefPubMed
44.
Zurück zum Zitat Hoirisch-Clapauch S, Nardi AE. Psychiatric remission with warfarin: should psychosis be addressed as plasminogen activator imbalance? Med Hypotheses. 2013;80(2):137–41.CrossRefPubMed Hoirisch-Clapauch S, Nardi AE. Psychiatric remission with warfarin: should psychosis be addressed as plasminogen activator imbalance? Med Hypotheses. 2013;80(2):137–41.CrossRefPubMed
45.
Zurück zum Zitat Hoirisch-Clapauch S, Nardi AE. Markers of low activity of tissue plasminogen activator/plasmin are prevalent in schizophreniapatients. Schizophr Res. 2014;159(1):118–23.CrossRefPubMed Hoirisch-Clapauch S, Nardi AE. Markers of low activity of tissue plasminogen activator/plasmin are prevalent in schizophreniapatients. Schizophr Res. 2014;159(1):118–23.CrossRefPubMed
46.
Zurück zum Zitat Hoirisch-Clapauch S, Amaral OB, Mezzasalma MA, Panizzutti R, Nardi AE. Dysfunction in the coagulation system andschizophrenia. Transl Psychiatry. 2016;6:e704.CrossRefPubMedPubMedCentral Hoirisch-Clapauch S, Amaral OB, Mezzasalma MA, Panizzutti R, Nardi AE. Dysfunction in the coagulation system andschizophrenia. Transl Psychiatry. 2016;6:e704.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat del Rio-Casanova L, Paz-Silva E, Requena-Caballero I, Diaz-Llenderrozas F, Gomez-Trigo Baldominos J, de la Cruz-Davila A, Paramo-Fernandez M. Psychosis as debut of antiphospholipid syndrome. Rev Neurol. 2014;58(11):500–4.PubMed del Rio-Casanova L, Paz-Silva E, Requena-Caballero I, Diaz-Llenderrozas F, Gomez-Trigo Baldominos J, de la Cruz-Davila A, Paramo-Fernandez M. Psychosis as debut of antiphospholipid syndrome. Rev Neurol. 2014;58(11):500–4.PubMed
48.
Zurück zum Zitat Braz Ade S, Capriglione ML, Sarmento JF. Extensive cutaneous necrosis as an initial manifestation of secondary antiphospholipidsyndrome (APS). Acta Reumatol Port. 2010;35(2):244–8.PubMed Braz Ade S, Capriglione ML, Sarmento JF. Extensive cutaneous necrosis as an initial manifestation of secondary antiphospholipidsyndrome (APS). Acta Reumatol Port. 2010;35(2):244–8.PubMed
49.
Zurück zum Zitat Lai JY, Wu PC, Chen HC, Lee MB. Early neuropsychiatric involvement inantiphospholipid syndrome. Gen Hosp Psychiatry. 2012;34(5):579.e1–3.CrossRef Lai JY, Wu PC, Chen HC, Lee MB. Early neuropsychiatric involvement inantiphospholipid syndrome. Gen Hosp Psychiatry. 2012;34(5):579.e1–3.CrossRef
50.
Zurück zum Zitat Manna R, Ricci V, Curigliano V, Pomponi M, Adamo F, Costa A, De Socio G, Garbarrini G, D’Onofrio F, Bria P. Psychiatric manifestations as a primary symptom inantiphospholipid syndrome. Int J Immunopathol Pharmacol. 2006;19(4):915–7.CrossRefPubMed Manna R, Ricci V, Curigliano V, Pomponi M, Adamo F, Costa A, De Socio G, Garbarrini G, D’Onofrio F, Bria P. Psychiatric manifestations as a primary symptom inantiphospholipid syndrome. Int J Immunopathol Pharmacol. 2006;19(4):915–7.CrossRefPubMed
51.
Zurück zum Zitat Taipa R, Santos E. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures. Lupus. 2011;20(13):1433–5.CrossRefPubMed Taipa R, Santos E. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures. Lupus. 2011;20(13):1433–5.CrossRefPubMed
52.
Zurück zum Zitat Shabana M, Shalaby M, Alhumayed S, et al. Paediatric case report: primary antiphospholipid syndrome presented with non-thrombotic neurological picture psychosis; treat by antidepressants alone? Int J Rheum Dis. 2009;12(2):170–3.CrossRefPubMed Shabana M, Shalaby M, Alhumayed S, et al. Paediatric case report: primary antiphospholipid syndrome presented with non-thrombotic neurological picture psychosis; treat by antidepressants alone? Int J Rheum Dis. 2009;12(2):170–3.CrossRefPubMed
53.
Zurück zum Zitat Sokol DK, Chen LS, Wagenknecht DR, et al. Anti-phospholipid antibodies in cerebrospinal fluid but not serum from a boy with psychosis. Pediatr Neurol. 2008;39(4):293–4.CrossRefPubMed Sokol DK, Chen LS, Wagenknecht DR, et al. Anti-phospholipid antibodies in cerebrospinal fluid but not serum from a boy with psychosis. Pediatr Neurol. 2008;39(4):293–4.CrossRefPubMed
Metadaten
Titel
Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature
verfasst von
Pikman Regina
Rotman Pnina
Aiman Natur
Levy Yair
Publikationsdatum
19.01.2017
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 2/2017
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-017-8895-1

Weitere Artikel der Ausgabe 2/2017

Immunologic Research 2/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.